305 related articles for article (PubMed ID: 33777961)
1. The Transcription Factor C/EBPβ Promotes HFL-1 Cell Migration, Proliferation, and Inflammation by Activating lncRNA HAS2-AS1 in Hypoxia.
Yang X; Qi F; Wei S; Lin L; Liu X
Front Cell Dev Biol; 2021; 9():651913. PubMed ID: 33777961
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HAS2-AS1 Promotes Glioblastoma Proliferation by Sponging miR-137.
Lu Y; Guo G; Hong R; Chen X; Sun Y; Liu F; Zhang Z; Jin X; Dong J; Yu K; Yang X; Nan Y; Huang Q
Front Oncol; 2021; 11():634893. PubMed ID: 34094916
[TBL] [Abstract][Full Text] [Related]
5. LncRNA PAXIP1-AS1 fosters the pathogenesis of pulmonary arterial hypertension via ETS1/WIPF1/RhoA axis.
Song R; Lei S; Yang S; Wu SJ
J Cell Mol Med; 2021 Aug; 25(15):7321-7334. PubMed ID: 34245091
[TBL] [Abstract][Full Text] [Related]
6. The human hyaluronan synthase 2 (HAS2) gene and its natural antisense RNA exhibit coordinated expression in the renal proximal tubular epithelial cell.
Michael DR; Phillips AO; Krupa A; Martin J; Redman JE; Altaher A; Neville RD; Webber J; Kim MY; Bowen T
J Biol Chem; 2011 Jun; 286(22):19523-32. PubMed ID: 21357421
[TBL] [Abstract][Full Text] [Related]
7. STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p/GOLM1 axis.
Bai M; Wu ZZ; Huang YL; Ke J; Xu Q; Wang X
J Gene Med; 2021 Jul; 23(7):e3338. PubMed ID: 33822440
[TBL] [Abstract][Full Text] [Related]
8. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HAS2-AS1 accelerates non-small cell lung cancer chemotherapy resistance by targeting LSD1/EphB3 pathway.
Sun P; Sun L; Cui J; Liu L; He Q
Am J Transl Res; 2020; 12(3):950-958. PubMed ID: 32269726
[TBL] [Abstract][Full Text] [Related]
10. HAS2-AS1 is a novel LH/hCG target gene regulating HAS2 expression and enhancing cumulus cells migration.
Yung Y; Ophir L; Yerushalmi GM; Baum M; Hourvitz A; Maman E
J Ovarian Res; 2019 Feb; 12(1):21. PubMed ID: 30819231
[TBL] [Abstract][Full Text] [Related]
11. CREB1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis.
Tong L; Wang Y; Ao Y; Sun X
Biomed Pharmacother; 2019 Jul; 115():108891. PubMed ID: 31082772
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HAS2-AS1 promotes tumor progression in glioblastoma via functioning as a competing endogenous RNA.
Zhang L; Wang H; Xu M; Chen F; Li W; Hu H; Yuan Q; Su Y; Liu X; Wuri J; Yan T
J Cell Biochem; 2020 Jan; 121(1):661-671. PubMed ID: 31385362
[TBL] [Abstract][Full Text] [Related]
13. Silencing of HAS2-AS1 mediates PI3K/AKT signaling pathway to inhibit cell proliferation, migration, and invasion in glioma.
Zhao Z; Liang T; Feng S
J Cell Biochem; 2019 Jul; 120(7):11510-11516. PubMed ID: 30790335
[TBL] [Abstract][Full Text] [Related]
14. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
15. Overexpressed lncRNA AC068039.4 Contributes to Proliferation and Cell Cycle Progression of Pulmonary Artery Smooth Muscle Cells Via Sponging miR-26a-5p/TRPC6 in Hypoxic Pulmonary Arterial Hypertension.
Qin Y; Zhu B; Li L; Wang D; Qiao Y; Liu B; Luo E; Hou J; Yan G; Tang C
Shock; 2021 Feb; 55(2):244-255. PubMed ID: 33026218
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
18. LncRNA RHPN1-AS1 Targeting miR-625/REG3A Promotes Cell Proliferation And Invasion Of Glioma Cells.
Cui P; Su J; Li Q; Xu G; Zhu N
Onco Targets Ther; 2019; 12():7911-7921. PubMed ID: 31576148
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
20. Macrophages-derived exosomal lncRNA LIFR-AS1 promotes osteosarcoma cell progression via miR-29a/NFIA axis.
Zhang H; Yu Y; Wang J; Han Y; Ren T; Huang Y; Chen C; Huang Q; Wang W; Niu J; Lou J; Guo W
Cancer Cell Int; 2021 Apr; 21(1):192. PubMed ID: 33794884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
